Business Segments · Depreciation
Life Sciences — Depreciation
Danaher Life Sciences — Depreciation increased by 2.1% to $48.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.1%, from $44.00M to $48.00M. Over 2 years (FY 2023 to FY 2025), Life Sciences — Depreciation shows an upward trend with a 19.8% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025
How to read this metric
Higher depreciation relative to revenue may indicate a capital-intensive manufacturing base or aging equipment requiring replacement.
Detailed definition
The systematic allocation of the cost of tangible fixed assets over their useful lives within the Life Sciences segment....
Peer comparison
Standard across manufacturing companies; peers with similar capital bases will show comparable depreciation patterns.
Metric ID:
dhr_segment_life_sciences_depreciationHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.25M | $32.25M | $32.25M | $32.25M | $38.00M | $41.00M | $44.00M | $44.00M | $45.00M | $45.00M | $47.00M | $48.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +17.8% | +7.9% | +7.3% | +0.0% | +2.3% | +0.0% | +4.4% | +2.1% |
| YoY Change | — | — | — | — | +17.8% | +27.1% | +36.4% | +36.4% | +18.4% | +9.8% | +6.8% | +9.1% |
Range$32.25M – $48.00M
CAGR+15.6%
Avg YoY Growth+20.2%
Median YoY Growth+18.1%
Current Streak11+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — depreciation?
- Danaher (DHR) reported life sciences — depreciation of $48.00M in Q4 2025.
- How has Danaher's life sciences — depreciation changed year-over-year?
- Danaher's life sciences — depreciation increased by 9.1% year-over-year, from $44.00M to $48.00M.
- What is the long-term trend for Danaher's life sciences — depreciation?
- Over 2 years (2023 to 2025), Danaher's life sciences — depreciation has grown at a 19.8% compound annual growth rate (CAGR), from $129.00M to $185.00M.
- What does life sciences — depreciation mean?
- The portion of tangible asset costs recognized as an expense during the period.